vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.
LINKBANCORP, Inc. is the larger business by last-quarter revenue ($46.0M vs $31.1M, roughly 1.5× LIFECORE BIOMEDICAL, INC. \DE\). LINKBANCORP, Inc. runs the higher net margin — 6.4% vs -32.1%, a 38.5% gap on every dollar of revenue. On growth, LINKBANCORP, Inc. posted the faster year-over-year revenue change (7.3% vs -4.5%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $25.0K). Over the past eight quarters, LINKBANCORP, Inc.'s revenue compounded faster (6.6% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
LFCR vs LNKB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $46.0M |
| Net Profit | $-10.0M | $2.9M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 8.5% |
| Net Margin | -32.1% | 6.4% |
| Revenue YoY | -4.5% | 7.3% |
| Net Profit YoY | -52.0% | -61.2% |
| EPS (diluted) | $-0.29 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $46.0M | ||
| Q3 25 | $31.1M | $44.8M | ||
| Q2 25 | — | $42.3M | ||
| Q1 25 | $35.2M | $53.4M | ||
| Q4 24 | $32.6M | $42.9M | ||
| Q3 24 | $24.7M | $42.9M | ||
| Q2 24 | — | $41.3M | ||
| Q1 24 | $35.7M | $40.5M |
| Q4 25 | — | $2.9M | ||
| Q3 25 | $-10.0M | $7.8M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | $-14.8M | $15.3M | ||
| Q4 24 | $-6.6M | $7.6M | ||
| Q3 24 | $-16.2M | $7.1M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | $15.6M | $5.7M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 8.5% | ||
| Q3 25 | -9.9% | 22.3% | ||
| Q2 25 | — | 22.4% | ||
| Q1 25 | -25.7% | 36.0% | ||
| Q4 24 | -6.0% | 22.6% | ||
| Q3 24 | -46.9% | 21.3% | ||
| Q2 24 | — | 18.0% | ||
| Q1 24 | -2.5% | 18.1% |
| Q4 25 | — | 6.4% | ||
| Q3 25 | -32.1% | 17.5% | ||
| Q2 25 | — | 17.5% | ||
| Q1 25 | -42.0% | 28.7% | ||
| Q4 24 | -20.2% | 17.7% | ||
| Q3 24 | -65.7% | 16.5% | ||
| Q2 24 | — | 14.1% | ||
| Q1 24 | 43.8% | 14.1% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | $-0.29 | $0.21 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | $-0.47 | $0.41 | ||
| Q4 24 | $-0.25 | $0.21 | ||
| Q3 24 | $-0.53 | $0.19 | ||
| Q2 24 | — | $0.16 | ||
| Q1 24 | $0.42 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $52.3M |
| Total DebtLower is stronger | $136.0M | $177.3M |
| Stockholders' EquityBook value | $-10.5M | $306.4M |
| Total Assets | $235.2M | $3.1B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $52.3M | ||
| Q3 25 | $18.9M | $194.2M | ||
| Q2 25 | — | $155.1M | ||
| Q1 25 | $5.4M | $220.2M | ||
| Q4 24 | $9.5M | $166.1M | ||
| Q3 24 | — | $191.2M | ||
| Q2 24 | — | $181.7M | ||
| Q1 24 | — | $172.3M |
| Q4 25 | — | $177.3M | ||
| Q3 25 | $136.0M | $102.3M | ||
| Q2 25 | — | $102.3M | ||
| Q1 25 | $124.9M | $102.7M | ||
| Q4 24 | $111.3M | $112.5M | ||
| Q3 24 | $106.3M | $102.4M | ||
| Q2 24 | — | $102.3M | ||
| Q1 24 | $97.1M | $102.2M |
| Q4 25 | — | $306.4M | ||
| Q3 25 | $-10.5M | $305.5M | ||
| Q2 25 | — | $298.0M | ||
| Q1 25 | $2.2M | $294.1M | ||
| Q4 24 | $15.4M | $280.2M | ||
| Q3 24 | $-3.9M | $277.4M | ||
| Q2 24 | — | $271.4M | ||
| Q1 24 | $17.7M | $268.2M |
| Q4 25 | — | $3.1B | ||
| Q3 25 | $235.2M | $3.1B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | $237.7M | $2.9B | ||
| Q4 24 | $255.4M | $2.9B | ||
| Q3 24 | $246.8M | $2.9B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | $246.2M | $2.8B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | 56.05× | 0.35× | ||
| Q4 24 | 7.20× | 0.40× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | 5.49× | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $25.3M |
| Free Cash FlowOCF − Capex | $25.0K | $23.8M |
| FCF MarginFCF / Revenue | 0.1% | 51.7% |
| Capex IntensityCapex / Revenue | 5.6% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 8.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $25.3M | ||
| Q3 25 | $1.8M | $23.6M | ||
| Q2 25 | — | $6.3M | ||
| Q1 25 | $1.2M | $2.6M | ||
| Q4 24 | $-6.1M | $25.4M | ||
| Q3 24 | $-613.0K | $14.0M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | $-1.4M | $-771.0K |
| Q4 25 | — | $23.8M | ||
| Q3 25 | $25.0K | $23.2M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | $-4.3M | $2.2M | ||
| Q4 24 | $-8.6M | $22.6M | ||
| Q3 24 | $-4.0M | $13.1M | ||
| Q2 24 | — | $6.3M | ||
| Q1 24 | $-7.8M | $-1.2M |
| Q4 25 | — | 51.7% | ||
| Q3 25 | 0.1% | 51.8% | ||
| Q2 25 | — | 14.5% | ||
| Q1 25 | -12.1% | 4.2% | ||
| Q4 24 | -26.3% | 52.6% | ||
| Q3 24 | -16.3% | 30.5% | ||
| Q2 24 | — | 15.3% | ||
| Q1 24 | -21.8% | -3.0% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 5.6% | 0.8% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | 15.5% | 0.7% | ||
| Q4 24 | 7.5% | 6.7% | ||
| Q3 24 | 13.9% | 2.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 17.8% | 1.1% |
| Q4 25 | — | 8.59× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 3.35× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | -0.09× | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
LNKB
Segment breakdown not available.
